Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Osteoporosis

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 127 articles:
HTML format



Single Articles


    June 2022
  1. OHEIM R, Tsourdi E, Seefried L, Beller G, et al
    Genetic Diagnostics in Routine Osteological Assessment of Adult Low Bone Mass Disorders.
    J Clin Endocrinol Metab. 2022;107:e3048-e3057.
    PubMed     Abstract available


    May 2022
  2. ENSRUD KE, Lui LY, Crandall CJ, Orwoll ES, et al
    Repeat Bone Mineral Density Screening Measurement and Fracture Prediction in Older Men: A Prospective Cohort Study.
    J Clin Endocrinol Metab. 2022 May 19. pii: 6589466. doi: 10.1210.
    PubMed     Abstract available


  3. COMNINOS AN, Hansen MS, Courtney A, Choudhury S, et al
    Acute Effects of Kisspeptin Administration on Bone Metabolism in Healthy Men.
    J Clin Endocrinol Metab. 2022;107:1529-1540.
    PubMed     Abstract available


  4. CIUFFI S, Marini F, Fossi C, Donati S, et al
    Circulating microRNAs as biomarkers of osteoporosis and fragility fractures.
    J Clin Endocrinol Metab. 2022 May 9. pii: 6582745. doi: 10.1210.
    PubMed     Abstract available


  5. CARWILE JL, Seshasayee SM, Ahrens KA, Hauser R, et al
    Serum PFAS and Urinary Phthalate Biomarker Concentrations and Bone Mineral Density in 12-19 Year Olds: 2011-2016 NHANES.
    J Clin Endocrinol Metab. 2022 May 3. pii: 6575101. doi: 10.1210.
    PubMed     Abstract available


    April 2022
  6. AGARWAL S, Shane E, Lang T, Shiau S, et al
    Spine volumetric BMD and strength in premenopausal idiopathic osteoporosis: Effects of teriparatide followed by denosumab.
    J Clin Endocrinol Metab. 2022 Apr 16. pii: 6569192. doi: 10.1210.
    PubMed     Abstract available


  7. YOO JE, Yoon JW, Park HE, Han K, et al
    Response to Letter to the Editor from Qingju Zhou: "Blood Pressure Variability and the Risk of Fracture: A Nationwide Cohort Study".
    J Clin Endocrinol Metab. 2022 Apr 4. pii: 6563352. doi: 10.1210.
    PubMed    


  8. ZHOU Q
    Letter to the Editor from Qingju Zhou: "Blood Pressure Variability and the Risk of Fracture: A Nationwide Cohort Study".
    J Clin Endocrinol Metab. 2022 Apr 4. pii: 6563351. doi: 10.1210.
    PubMed    


    March 2022
  9. FRARA S, Uygur MM, di Filippo L, Doga M, et al
    High Prevalence of Vertebral Fractures Associated with Preoperative GH Levels in Patients with recent Diagnosis of Acromegaly.
    J Clin Endocrinol Metab. 2022 Mar 29. pii: 6555665. doi: 10.1210.
    PubMed     Abstract available


  10. BORN C, Jakob F, Shojaa M, Kohl M, et al
    Effects of hormone therapy and exercise on bone mineral density in healthy women - A systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2022 Mar 24. pii: 6553368. doi: 10.1210.
    PubMed     Abstract available


  11. PENA DIAS J, Piggott DA, Sun J, Wehbeh L, et al
    SHBG, bone mineral density and physical function among injection drug users with and without HIV and HCV.
    J Clin Endocrinol Metab. 2022 Mar 16. pii: 6549479. doi: 10.1210.
    PubMed     Abstract available


    February 2022
  12. BALEANU F, Moreau M, Charles A, Iconaru L, et al
    Fragility fractures in postmenopausal women: development of 5-year prediction models using the FRISBEE study.
    J Clin Endocrinol Metab. 2022 Feb 17. pii: 6530319. doi: 10.1210.
    PubMed     Abstract available


    January 2022
  13. COLL JC, Garceau E, Leslie WD, Genest M, et al
    Prevalence of Vertebral Fractures in Adults with Type 1 Diabetes: DenSiFy Study (Diabetes Spine Fractures).
    J Clin Endocrinol Metab. 2022 Jan 28. pii: 6517001. doi: 10.1210.
    PubMed     Abstract available


  14. KLINE GA, Morin SN, Lix LM, Leslie WD, et al
    Divergent Patterns of Antifracture Medication Use Following Fracture on Therapy: A Population-Based Cohort Study.
    J Clin Endocrinol Metab. 2022;107:491-499.
    PubMed     Abstract available


    December 2021
  15. QUESTER J, Nethander M, Eriksson A, Ohlsson C, et al
    Endogenous DHEAS is Causally Linked with Lumbar Spine Bone Mineral Density and Forearm Fractures in Women.
    J Clin Endocrinol Metab. 2021 Dec 22. pii: 6479181. doi: 10.1210.
    PubMed     Abstract available


  16. COSENTINI D, Grisanti S, Hadoux J, Libe R, et al
    Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy.
    J Clin Endocrinol Metab. 2021 Dec 14. pii: 6461116. doi: 10.1210.
    PubMed     Abstract available


  17. WANG B, Wang Z, Poundarik AA, Zaki MJ, et al
    Unmasking Fracture Risk in Type 2 Diabetes: The Association of Longitudinal Glycemic Hemoglobin Level and Medications.
    J Clin Endocrinol Metab. 2021 Dec 9. pii: 6458464. doi: 10.1210.
    PubMed     Abstract available


    November 2021
  18. YOO JE, Yoon JW, Park HE, Han K, et al
    Blood pressure variability and the risk of fracture: a nationwide cohort study.
    J Clin Endocrinol Metab. 2021 Nov 28. pii: 6445180. doi: 10.1210.
    PubMed     Abstract available


  19. SHANE E, Shiau S, Recker RR, Lappe JM, et al
    Denosumab After Teriparatide in Premenopausal Women with Idiopathic Osteoporosis.
    J Clin Endocrinol Metab. 2021 Nov 24. pii: 6437931. doi: 10.1210.
    PubMed     Abstract available


  20. DAWOOD NB, Tseng CH, Nguyen DT, Yan KL, et al
    Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment.
    J Clin Endocrinol Metab. 2021;106:e4993-e5000.
    PubMed     Abstract available


    October 2021

  21. Corrigendum to: Genome-wide Association Study of Estradiol Levels and the Causal Effect of Estradiol on Bone Mineral Density.
    J Clin Endocrinol Metab. 2021 Oct 26. pii: 6410701. doi: 10.1210.
    PubMed    


    September 2021
  22. FERRARI S
    Short or long-term osteoporosis therapy with denosumab ?
    J Clin Endocrinol Metab. 2021 Sep 25. pii: 6375342. doi: 10.1210.
    PubMed    


  23. SHIEH A, Ruppert KM, Greendale GA, Lian Y, et al
    Associations of age at menopause with postmenopausal bone mineral density and fracture risk in women.
    J Clin Endocrinol Metab. 2021 Sep 19. pii: 6372418. doi: 10.1210.
    PubMed     Abstract available


    August 2021
  24. VIOLA V, Tramontana F, Leanza G
    Letter to the Editor from Viola Viola: "Diminishing Value from Multiple Serial Bone Densitometry in Women Receiving Antiresorptive Medication for Osteoporosis".
    J Clin Endocrinol Metab. 2021 Aug 14. pii: 6352412. doi: 10.1210.
    PubMed    


  25. KARAKILIC E, Saygili ES
    Letter to the Editor From Karakilic and Saygili:" Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes".
    J Clin Endocrinol Metab. 2021 Aug 13. pii: 6350455. doi: 10.1210.
    PubMed    


  26. KLINE GA, Morin SN, Feldman S, Lix LM, et al
    Response letter to the Editor from Dr. Viola et al. "Diminishing value from multiple serial bone densitometry in women receiving antiresorptive medication for osteoporosis."
    J Clin Endocrinol Metab. 2021 Aug 7. pii: 6345421. doi: 10.1210.
    PubMed    


  27. CROMER SJ, Yu EW
    Challenges and opportunities for osteoporosis care during the COVID-19 pandemic.
    J Clin Endocrinol Metab. 2021 Aug 3. pii: 6337853. doi: 10.1210.
    PubMed     Abstract available


    July 2021
  28. KU EJ, Yoo WS, Lee EK, Ahn HY, et al
    Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2021 Jul 24. pii: 6327817. doi: 10.1210.
    PubMed     Abstract available


  29. KUZMA M, Vanuga P, Sagova I, Pavai D, et al
    Vertebral fractures occur despite control of acromegaly and are predicted by cortical volumetric bone mineral density.
    J Clin Endocrinol Metab. 2021 Jul 16. pii: 6322668. doi: 10.1210.
    PubMed     Abstract available


  30. SCHMITZ D, Ek WE, Berggren E, Hoglund J, et al
    Genome-Wide Association Study of Estradiol Levels, and the Causal Effect of Estradiol on Bone Mineral Density.
    J Clin Endocrinol Metab. 2021 Jul 13. pii: 6320117. doi: 10.1210.
    PubMed     Abstract available


  31. WARD LM, Ma J, Robinson ME, Scharke M, et al
    Osteoporotic Fractures and Vertebral Body Reshaping in Children with Glucocorticoid-Treated Rheumatic Disorders.
    J Clin Endocrinol Metab. 2021 Jul 7. pii: 6316730. doi: 10.1210.
    PubMed     Abstract available


  32. WARD LM, Choudhury A, Alos N, Cabral DA, et al
    Zoledronic acid versus placebo in pediatric glucocorticoid-induced osteoporosis: A randomized double-blind phase 3 trial.
    J Clin Endocrinol Metab. 2021 Jul 6. pii: 6316209. doi: 10.1210.
    PubMed     Abstract available


  33. LING CW, Miao Z, Xiao ML, Zhou H, et al
    The Association of Gut Microbiota with Osteoporosis is Mediated by Amino Acid Metabolism: Multiomics in a Large Cohort.
    J Clin Endocrinol Metab. 2021 Jul 2. pii: 6313243. doi: 10.1210.
    PubMed     Abstract available


  34. MITCHELL A, Fall T, Melhus H, Lind L, et al
    Type 2 diabetes and Change in Total Hip Bone Area and Bone Mineral Density in Elderly Swedish Men and Women.
    J Clin Endocrinol Metab. 2021 Jul 2. pii: 6313244. doi: 10.1210.
    PubMed     Abstract available


    June 2021
  35. YOKOMOTO-UMAKOSHI M, Umakoshi H, Iwahashi N, Matsuda Y, et al
    Protective Role of DHEAS in Age-related Changes in Bone Mass and Fracture Risk: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2021 Jun 22. pii: 6307743. doi: 10.1210.
    PubMed     Abstract available


  36. YOKOMOTO-UMAKOSHI M, Umakoshi H, Iwahashi N, Matsuda Y, et al
    Protective Role of DHEAS in Age-related Changes in Bone Mass and Fracture Risk.
    J Clin Endocrinol Metab. 2021 Jun 22. pii: 6307743. doi: 10.1210.
    PubMed     Abstract available


  37. CHAPURLAT R
    Of the Futility of Repeating BMD Measurement in Treated Osteoporotic Women.
    J Clin Endocrinol Metab. 2021 Jun 17. pii: 6303538. doi: 10.1210.
    PubMed    


    May 2021
  38. KIM JA, Lee JS, Song E, Roh E, et al
    Association between Visit-to-Visit Fasting Plasma Glucose Variability and Osteoporotic Fractures in nondiabetic subjects.
    J Clin Endocrinol Metab. 2021 May 26. pii: 6284334. doi: 10.1210.
    PubMed     Abstract available


  39. ZAWORSKI C, Cheah J, Koff MF, Breighner R, et al
    MRI-based texture analysis of trabecular bone for opportunistic screening of skeletal fragility.
    J Clin Endocrinol Metab. 2021 May 17. pii: 6276953. doi: 10.1210.
    PubMed     Abstract available


  40. MAKRAS P, Appelman-Dijkstra NM, Papapoulos SE, van Wissen S, et al
    The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation.
    J Clin Endocrinol Metab. 2021 May 12. pii: 6274510. doi: 10.1210.
    PubMed     Abstract available


  41. ZHU J, Briganti EM
    Letter to the Editor from Jasmine Zhu: Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease.
    J Clin Endocrinol Metab. 2021 May 6. pii: 6268612. doi: 10.1210.
    PubMed    



  42. Corrigendum to: "Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: a 2-Year RCT".
    J Clin Endocrinol Metab. 2021 May 4. pii: 6263815. doi: 10.1210.
    PubMed    


    April 2021
  43. SHIEH A, Karlamangla AS, Huang MH, Han W, et al
    Faster lumbar spine bone loss in midlife predicts subsequent fracture independent of starting bone mineral density.
    J Clin Endocrinol Metab. 2021 Apr 27. pii: 6254916. doi: 10.1210.
    PubMed     Abstract available


  44. CIARDULLO S, Muraca E, Zerbini F, Manzoni G, et al
    NAFLD and liver fibrosis are not associated with reduced femoral bone mineral density in the general US population.
    J Clin Endocrinol Metab. 2021 Apr 20. pii: 6241840. doi: 10.1210.
    PubMed     Abstract available


    March 2021
  45. KLINE GA, Morin SN, Feldman S, Lix LM, et al
    Diminishing value from multiple serial bone densitometry in women receiving anti-resorptive medication for osteoporosis.
    J Clin Endocrinol Metab. 2021 Mar 30. pii: 6204740. doi: 10.1210.
    PubMed     Abstract available


  46. REEVES KW, Vieyra G, Grimes NP, Meliker J, et al
    Urinary Phthalate Biomarkers and Bone Mineral Density in Postmenopausal Women.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6180137. doi: 10.1210.
    PubMed     Abstract available


  47. LANGDAHL BL, Hofbauer LC, Forfar JC
    Cardiovascular Safety and Sclerostin Inhibition - a mini-review.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6182322. doi: 10.1210.
    PubMed     Abstract available


  48. XUE S, Zhang Y, Qiao W, Zhao Q, et al
    An Updated Reference for Calculating Bone Mineral Density T-Scores.
    J Clin Endocrinol Metab. 2021 Mar 18. pii: 6178347. doi: 10.1210.
    PubMed     Abstract available


  49. NG TANG FUI M, Hoermann R, Bracken K, Handelsman DJ, et al
    Effect of Testosterone treatment on bone microarchitecture and bone mineral density in men: a two-year RCT.
    J Clin Endocrinol Metab. 2021 Mar 8. pii: 6162862. doi: 10.1210.
    PubMed     Abstract available


  50. GONG R, Xiao HM, Zhang YH, Zhao Q, et al
    Identification and Functional Characterization of Metabolites for Bone Mass in Peri-/Post-menopausal Chinese Women.
    J Clin Endocrinol Metab. 2021 Mar 8. pii: 6161511. doi: 10.1210.
    PubMed     Abstract available


    February 2021

  51. Corrigendum to: "Comparison of Fracture Risk Prediction by the US Preventive Services Task Force Strategy and Two Alternative Strategies in Women 50-64 Years Old in the Women's Health Initiative".
    J Clin Endocrinol Metab. 2021 Feb 23. pii: 6146952. doi: 10.1210.
    PubMed    


  52. QU Z, Yang F, Yan Y, Hong J, et al
    Relationship between serum nutritional factors and bone mineral density: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2021 Feb 13. pii: 6134779. doi: 10.1210.
    PubMed     Abstract available


  53. CIPRIANI C, Minisola S, Bilezikian JP, Diacinti D, et al
    Vertebral Fracture Assessment in postmenopausal women with post-surgical hypoparathyroidism.
    J Clin Endocrinol Metab. 2021 Feb 10. pii: 6132444. doi: 10.1210.
    PubMed     Abstract available


  54. VIGEVANO F, Gregori G, Colleluori G, Chen R, et al
    In Men With Obesity, T2DM Is Associated With Poor Trabecular Microarchitecture and Bone Strength, and Low Bone Turnover.
    J Clin Endocrinol Metab. 2021 Feb 4. pii: 6127536. doi: 10.1210.
    PubMed     Abstract available


    January 2021
  55. KONG SH, Kim JH, Shin CS
    Serum Spermidine as a Novel Potential Predictor for Fragility Fractures.
    J Clin Endocrinol Metab. 2021;106:e582-e591.
    PubMed     Abstract available


  56. MISRA M, Bredella MA
    Bone Metabolism in Adolescents Undergoing Bariatric Surgery.
    J Clin Endocrinol Metab. 2021;106:326-336.
    PubMed     Abstract available


  57. DREYER P, Palomo T, Brandao CMA, Vieira JGH, et al
    Letter to the Editor from Dreyer, et al: "Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF".
    J Clin Endocrinol Metab. 2021 Jan 22. pii: 6114543. doi: 10.1210.
    PubMed    


  58. YUAN S, Wan ZH, Cheng SL, Michaelsson K, et al
    Insulin-like Growth Factor-1, Bone Mineral Density, and Fracture: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2021 Jan 19. pii: 6104229. doi: 10.1210.
    PubMed     Abstract available



  59. Corrigendum to: "Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF".
    J Clin Endocrinol Metab. 2021 Jan 13. pii: 6094895. doi: 10.1210.
    PubMed    


  60. HANNEMANN A, Nauck M, Volzke H, Weidner H, et al
    Interactions of Anemia, FGF-23, and Bone in Healthy Adults-Results From the Study of Health in Pomerania (SHIP).
    J Clin Endocrinol Metab. 2021;106:e288-e299.
    PubMed     Abstract available


    November 2020
  61. FENG SH, Huang YP, Yeh KC, Pan SL, et al
    Osteoporosis and the risk of Parkinson's disease: A nationwide propensity score-matched longitudinal follow-up study.
    J Clin Endocrinol Metab. 2020 Nov 25. pii: 6000490. doi: 10.1210.
    PubMed     Abstract available


  62. BROADWELL A, Chines A, Ebeling PR, Franek E, et al
    Denosumab Safety and Efficacy Among Subjects in the FREEDOM Extension Study With Mild-to-Moderate Chronic Kidney Disease.
    J Clin Endocrinol Metab. 2020 Nov 19. pii: 5992310. doi: 10.1210.
    PubMed     Abstract available


  63. HOFSO D, Hillestad TOW, Halvorsen E, Fatima F, et al
    Bone mineral density and bone turnover after sleeve gastrectomy and gastric bypass, a randomized controlled trial.
    J Clin Endocrinol Metab. 2020 Nov 5. pii: 5956311. doi: 10.1210.
    PubMed     Abstract available


  64. CHARLIER S, Vavanikunnel J, Becker C, Jick SS, et al
    Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study.
    J Clin Endocrinol Metab. 2020 Nov 3. pii: 5952698. doi: 10.1210.
    PubMed     Abstract available


    October 2020
  65. TSOURDI E, Zillikens MC, Meier C, Body JJ, et al
    Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS.
    J Clin Endocrinol Metab. 2020 Oct 26. pii: 5939974. doi: 10.1210.
    PubMed     Abstract available


  66. DI FILIPPO L, Formenti AM, Doga M, Pedone E, et al
    Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes.
    J Clin Endocrinol Metab. 2020 Oct 21. pii: 5923308. doi: 10.1210.
    PubMed     Abstract available


  67. COHEN A, Shiau S, Nair N, Recker RR, et al
    Effect of Teriparatide on Bone Remodeling and Density in Premenopausal Idiopathic Osteoporosis: A Phase II Trial.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    September 2020
  68. LANGDAHL B
    Treatment of premenopausal women with osteoporosis.
    J Clin Endocrinol Metab. 2020 Sep 22. pii: 5910063. doi: 10.1210.
    PubMed    


  69. KREZ A, Agarwal S, Bucovsky M, McMahon DJ, et al
    Long-term Bone Loss and Deterioration of Microarchitecture After Gastric Bypass in African American and Latina Women.
    J Clin Endocrinol Metab. 2020 Sep 16. pii: 5906394. doi: 10.1210.
    PubMed     Abstract available


  70. VAN SANTEN SS, Olsson DS, Hammarstrand C, Wijnen M, et al
    Body composition and bone mineral density in craniopharyngioma patients: a longitudinal study over 10 years.
    J Clin Endocrinol Metab. 2020 Sep 1. pii: 5900043. doi: 10.1210.
    PubMed     Abstract available


    August 2020
  71. QU Z, Yang F, Hong J, Wang W, et al
    Parathyroid hormone and bone mineral density: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2020 Aug 22. pii: 5896008. doi: 10.1210.
    PubMed     Abstract available


  72. LIU Y, Shen H, Greenbaum J, Liu A, et al
    Gene Expression and RNA Splicing Imputation Identifies Novel Candidate Genes Associated with Osteoporosis.
    J Clin Endocrinol Metab. 2020 Aug 21. pii: 5895512. doi: 10.1210.
    PubMed     Abstract available


  73. LEDER BZ, Mitlak B, Hu MY, Hattersley G, et al
    ERRATUMERRATUM for "Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis".
    J Clin Endocrinol Metab. 2020;105.
    PubMed    


    July 2020
  74. RODRIGUEZ AJ, Ernst MT, Nybo M, Prieto-Alhambra D, et al
    Oral bisphosphonate use reduces cardiovascular events in a cohort of Danish patients referred for bone mineral density.
    J Clin Endocrinol Metab. 2020 Jul 27. pii: 5876920. doi: 10.1210.
    PubMed     Abstract available


  75. DIKER-COHEN T, Rosenberg D, Avni T, Shepshelovich D, et al
    Response to Letter to the Editor from Min Gong et al: (Risk for Infections During Treatment with Denosumab for Osteoporosis: a Systematic Review and Meta-analysis).
    J Clin Endocrinol Metab. 2020 Jul 17. pii: 5873223. doi: 10.1210.
    PubMed    


  76. GONG M, Huang G, Xu C
    Letter to the Editor from Min Gong et al: (Risk for Infections During Treatment with Denosumab for Osteoporosis: a Systematic Review and Meta-analysis).
    J Clin Endocrinol Metab. 2020 Jul 17. pii: 5873220. doi: 10.1210.
    PubMed    


  77. RACHNER TD, Gobel A, Jaschke NP, Hofbauer LC, et al
    Challenges in preventing bone loss induced by aromatase inhibitors.
    J Clin Endocrinol Metab. 2020 Jul 16. pii: 5872610. doi: 10.1210.
    PubMed     Abstract available


  78. COSMAN F, Peterson LR, Towler DA, Mitlak B, et al
    Cardiovascular Safety of Abaloparatide in Postmenopausal Women with Osteoporosis: Analysis from the ACTIVE Phase 3 Trial.
    J Clin Endocrinol Metab. 2020 Jul 13. pii: 5870711. doi: 10.1210.
    PubMed     Abstract available


  79. ALAJLOUNI D, Bliuc D, Tran T, Eisman JA, et al
    Decline in muscle strength and performance predicts fracture risk in elderly women and men.
    J Clin Endocrinol Metab. 2020 Jul 8. pii: 5868761. doi: 10.1210.
    PubMed     Abstract available


    June 2020
  80. KINDLER JM, Kalkwarf HJ, Lappe JM, Gilsanz V, et al
    Pediatric Reference Ranges for Ultradistal Radius Bone Density: Results from the Bone Mineral Density in Childhood Study.
    J Clin Endocrinol Metab. 2020 Jun 19. pii: 5860168. doi: 10.1210.
    PubMed     Abstract available


  81. MAZZIOTTI G, Betella N, Lania AG
    Letter to the Editor: ["Delayed Denosumab Injections and Bone Mineral Density Response: En Electronic Health Record-Based Study"].
    J Clin Endocrinol Metab. 2020 Jun 17. pii: 5859156. doi: 10.1210.
    PubMed    


  82. YAVROPOULOU MP, Anastasilakis AD, Makras P, Papatheodorou A, et al
    Serum profile of microRNAs linked to bone metabolism during sequential treatment for postmenopausal osteoporosis.
    J Clin Endocrinol Metab. 2020 Jun 10. pii: 5855767. doi: 10.1210.
    PubMed     Abstract available


  83. ZHANG L, Peng TL, Wang L, Meng XH, et al
    Network-Based Transcriptome-Wide Expression Study for Postmenopausal Osteoporosis.
    J Clin Endocrinol Metab. 2020 Jun 1. pii: 5850085. doi: 10.1210.
    PubMed     Abstract available


    May 2020
  84. PEPE J, Body JJ, Hadji P, McCloskey E, et al
    Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF.
    J Clin Endocrinol Metab. 2020 May 26. pii: 5846185. doi: 10.1210.
    PubMed     Abstract available


  85. DIKER-COHEN T, Rosenberg D, Avni T, Shepshelovich D, et al
    Response to Letter to the Editor: "Risk for Infections During Treatment with Denosumab for Osteoporosis: a Systematic Review and Meta-analysis".
    J Clin Endocrinol Metab. 2020 May 23. pii: 5843473. doi: 10.1210.
    PubMed    


  86. WATTS NB
    Letter to the editor: "Risk for Infections During Treatment with Denosumab for Osteoporosis: a Systematic Review and Meta-analysis".
    J Clin Endocrinol Metab. 2020 May 23. pii: 5843452. doi: 10.1210.
    PubMed    


  87. YEAP BB, Alfonso H, Chubb SAP, Center JR, et al
    U-Shaped Association of Plasma Testosterone, and no Association of Plasma Estradiol, with Incidence of Fractures in Men.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    April 2020
  88. NGUYEN TV
    Toward the era of precision fracture risk assessment.
    J Clin Endocrinol Metab. 2020 Apr 21. pii: 5823064. doi: 10.1210.
    PubMed    


  89. VAN SANTEN SS, Olsson DS, van den Heuvel-Eibrink MM, Wijnen M, et al
    Fractures, Bone Mineral Density, and Final Height in Craniopharyngioma Patients with a Follow-up of 16 Years.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


  90. NETHANDER M, Pettersson-Kymmer U, Vandenput L, Lorentzon M, et al
    BMD-Related Genetic Risk Scores Predict Site-Specific Fractures as Well as Trabecular and Cortical Bone Microstructure.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


  91. GREY A, Horne A, Gamble G, Mihov B, et al
    Ten Years of Very Infrequent Zoledronate Therapy in Older Women: An Open-Label Extension of a Randomized Trial.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    March 2020
  92. JAIN RK, Weiner MG, Zhao H, Vokes T, et al
    Comorbid conditions and GFR predict non-vertebral fractures in patients with diabetes in an ethnic-specific manner.
    J Clin Endocrinol Metab. 2020 Mar 20. pii: 5810272. doi: 10.1210.
    PubMed     Abstract available


  93. SHOBACK D, Rosen CJ, Black DM, Cheung AM, et al
    Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


  94. CIPRIANI C, Bilezikian JP
    Osteoanabolics Versus Antiresorptives: Which First?
    J Clin Endocrinol Metab. 2020;105.
    PubMed    


    February 2020
  95. LI GH, Chau YP, Cheung CL
    Response to Letter to the Editor: Serum Metabolome of Coffee Consumption and its Association with Bone Mineral Density: The Hong Kong Osteoporosis Study.
    J Clin Endocrinol Metab. 2020 Feb 18. pii: 5740110. doi: 10.1210.
    PubMed    


  96. KAWADA T
    Letter to the Editor: "Serum Metabolome of Coffee Consumption and its Association with Bone Mineral Density: The Hong Kong Osteoporosis Study".
    J Clin Endocrinol Metab. 2020 Feb 18. pii: 5740117. doi: 10.1210.
    PubMed    


    January 2020
  97. LUKERT BP
    Which Drug Next? Sequential Therapy for Osteoporosis.
    J Clin Endocrinol Metab. 2020 Jan 10. pii: 5700360. doi: 10.1210.
    PubMed     Abstract available


  98. YANG WP, Chang HH, Li HY, Lai YC, et al
    Iron Overload Associated Endocrine Dysfunction Leading to Lower Bone Mineral Density in Thalassemia Major.
    J Clin Endocrinol Metab. 2020 Jan 7. pii: 5697444. doi: 10.1210.
    PubMed     Abstract available


  99. DIKER-COHEN T, Rosenberg D, Avni T, Shepshelovich D, et al
    Risk for Infections During Treatment With Denosumab for Osteoporosis: a Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2020 Jan 3. pii: 5695688. doi: 10.1210.
    PubMed     Abstract available


  100. LYU H, Zhao SS, Yoshida K, Tedeschi SK, et al
    Delayed Denosumab Injections and Bone Mineral Density Response: An Electronic Health Record-based Study.
    J Clin Endocrinol Metab. 2020 Jan 2. pii: 5693392. doi: 10.1210.
    PubMed     Abstract available



  101. CORRIGENDUM for "Dietary Calcium Intake and Bone Loss Over 6 Years in Osteopenic Postmenopausal Women".
    J Clin Endocrinol Metab. 2020;105.
    PubMed    


  102. DING L, Hu J, Wang D, Liu Q, et al
    Efficacy and Safety of First- and Second-Line Drugs to Prevent Glucocorticoid-Induced Fractures.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    December 2019
  103. EL-HAJJ FULEIHAN G
    Building Bridges to Address the Osteoporosis Crisis.
    J Clin Endocrinol Metab. 2019 Dec 31. pii: 5691193. doi: 10.1210.
    PubMed    


  104. MA J, Lin X, Chen C, Li S, et al
    Circulating miR-181c-5p and miR-497-5p are potential biomarkers for prognosis and diagnosis of osteoporosis.
    J Clin Endocrinol Metab. 2019 Dec 24. pii: 5686162. doi: 10.1210.
    PubMed     Abstract available


  105. WARD LM, Weber DR, Munns CF, Hogler W, et al
    A Contemporary View of the Definition and Diagnosis of Osteoporosis in Children and Adolescents.
    J Clin Endocrinol Metab. 2019 Dec 22. pii: 5684884. doi: 10.1210.
    PubMed     Abstract available


  106. SHIEH A, Greendale GA, Cauley JA, Karlamangla AS, et al
    The association between fast increase in bone turnover during the menopause transition and subsequent fracture.
    J Clin Endocrinol Metab. 2019 Dec 16. pii: 5678661. doi: 10.1210.
    PubMed     Abstract available


  107. LI M, Yao S, Duan YY, Zhang YJ, et al
    Transcription Factor Enrichment Analysis in Enhancers Identifies EZH2 as A Susceptibility Gene for Osteoporosis.
    J Clin Endocrinol Metab. 2019 Dec 13. pii: 5675148. doi: 10.1210.
    PubMed     Abstract available


  108. MAIMOUN L, Garnero P, Mura T, Nocca D, et al
    Specific effects of anorexia nervosa and obesity on bone mineral density and bone turnover in young women.
    J Clin Endocrinol Metab. 2019 Dec 10. pii: 5672712. doi: 10.1210.
    PubMed     Abstract available


    November 2019
  109. CHAU YP, Au PCM, Li GHY, Sing CW, et al
    Serum Metabolome of Coffee Consumption and its Association with Bone Mineral Density: The Hong Kong Osteoporosis Study.
    J Clin Endocrinol Metab. 2019 Nov 21. pii: 5637088. doi: 10.1210.
    PubMed     Abstract available


  110. BLUMENFELD Z, Lavie G
    Menopausal transition bone loss- what are the practical implications.
    J Clin Endocrinol Metab. 2019 Nov 19. pii: 5629158. doi: 10.1210.
    PubMed    


  111. GONZALEZ RODRIGUEZ E, Stuber M, Del Giovane C, Feller M, et al
    Skeletal Effects of Levothyroxine for Subclinical Hypothyroidism in Older Adults: A TRUST Randomized Trial Nested Study.
    J Clin Endocrinol Metab. 2019 Nov 8. pii: 5614779. doi: 10.1210.
    PubMed     Abstract available


  112. HALPER-STROMBERG E, Gallo T, Champakanath A, Taki I, et al
    Bone Mineral Density across the Life-Span in Patients with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2019 Nov 2. pii: 5611085. doi: 10.1210.
    PubMed     Abstract available


  113. LEDER BZ, Mitlak B, Hu MY, Hattersley G, et al
    Effect of Abaloparatide Versus Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis.
    J Clin Endocrinol Metab. 2019 Nov 1. pii: 5610884. doi: 10.1210.
    PubMed     Abstract available


  114. RAMCHAND SK, David NL, Leder BZ, Tsai JN, et al
    Bone mineral density response with denosumab in combination with standard or high-dose teriparatide: the DATA-HD RCT.
    J Clin Endocrinol Metab. 2019 Nov 1. pii: 5610890. doi: 10.1210.
    PubMed     Abstract available


    October 2019
  115. ANAGNOSTIS P, Kenanidis E, Potoupnis M, Tsiridis E, et al
    Letter to the Editor: "Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline."
    J Clin Endocrinol Metab. 2019 Oct 28. pii: 5607923. doi: 10.1210.
    PubMed    


  116. KENDLER D, Chines A, Clark P, Ebeling PR, et al
    Bone Mineral Density After Transitioning From Denosumab to Alendronate.
    J Clin Endocrinol Metab. 2019 Oct 26. pii: 5607536. doi: 10.1210.
    PubMed     Abstract available


  117. LI GH, Robinson-Cohen C, Sahni S, Au PC, et al
    Association of Genetic Variants Related to Serum Calcium Levels with Reduced Bone Mineral Density.
    J Clin Endocrinol Metab. 2019 Oct 25. pii: 5606940. doi: 10.1210.
    PubMed     Abstract available


  118. LYU H, Zhao SS, Solomon DH
    Reply to Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".
    J Clin Endocrinol Metab. 2019 Oct 25. pii: 5606941. doi: 10.1210.
    PubMed    


  119. GEUSENS P, Marin F, Kendler DL
    Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".
    J Clin Endocrinol Metab. 2019 Oct 25. pii: 5606939. doi: 10.1210.
    PubMed    


  120. SUGIYAMA T
    Letter to the Editor: "Exercise mitigates bone loss in women with severe obesity after Roux-en-Y gastric bypass: a randomized controlled trial".
    J Clin Endocrinol Metab. 2019 Oct 23. pii: 5602688. doi: 10.1210.
    PubMed    


  121. MURAI IH, Roschel H, Gualano B
    Response to Letter to the Editor: "Exercise mitigates bone loss in women with severe obesity after Roux-en-Y gastric bypass: a randomized controlled trial".
    J Clin Endocrinol Metab. 2019 Oct 23. pii: 5602687. doi: 10.1210.
    PubMed    


  122. MERLOTTI D, Rendina D, Muscariello R, Picchioni T, et al
    PREVENTIVE ROLE OF VITAMIN D SUPPLEMENTATION FOR ACUTE PHASE REACTION AFTER BISPHOSPHONATE INFUSION IN PAGET'S DISEASE.
    J Clin Endocrinol Metab. 2019 Oct 22. pii: 5601913. doi: 10.1210.
    PubMed     Abstract available


  123. CHILOIRO S, Antonella G, Frara S, Bima C, et al
    Effects of Pegvisomant and Pasireotide LAR on vertebral fractures in acromegaly resistant to First-Generation SRLs.
    J Clin Endocrinol Metab. 2019 Oct 15. pii: 5588033. doi: 10.1210.
    PubMed     Abstract available


    September 2019
  124. ZHAO Z, Wang L, Fu Z, Ji L, et al
    The prevalence of osteoporosis tested by quantitative computed tomography in patients with different glucose tolerances.
    J Clin Endocrinol Metab. 2019 Sep 23. pii: 5572675. doi: 10.1210.
    PubMed     Abstract available


    May 2019
  125. BARRIONUEVO P, Kapoor E, Asi N, Alahdab F, et al
    Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis.
    J Clin Endocrinol Metab. 2019;104:1623-1630.
    PubMed     Abstract available


  126. ALOIA JF, Mikhail M, Fazzari M, Islam S, et al
    Physical Performance and Vitamin D in Elderly Black Women-The PODA Randomized Clinical Trial.
    J Clin Endocrinol Metab. 2019;104:1441-1448.
    PubMed     Abstract available


    March 2019
  127. CHEN SC, Shepherd S, McMillan M, McNeilly J, et al
    Skeletal Fragility & Its Clinical Determinants In Children With Type 1 Diabetes.
    J Clin Endocrinol Metab. 2019 Mar 8. pii: 5371250. doi: 10.1210/jc.2019-00084.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: